Impact of renal anatomy on flexible ureterorenoscopy with holmium laser lithotripsy. Outcomes for lower pole kidney stones

2016 ◽  
Vol 15 (11) ◽  
pp. e1452 ◽  
Author(s):  
T. Ürge ◽  
P. Běhounek ◽  
V. Janda ◽  
V. Eret ◽  
Z. Chudáček ◽  
...  
2018 ◽  
Vol 75 (10) ◽  
pp. 1030-1034
Author(s):  
Predrag Ilic ◽  
Dejan Kostic ◽  
Slobodan Dzambasanovic ◽  
Mirjana Jankovic ◽  
Vladimir Kojovic

Background/Aim. Renal stones located in the lower pole of kidney represent a serious challenge for surgical treatment in children. The options are: open surgery, extracorporeal shock-wave lithotripsy, percutaneous nephrolithotomy and retrograde intrarenal surgery. Reports about the endoscopic treatment in children are limited. The aim of the study was to evaluate the effectiveness of retrograde intrarenal surgery in pediatric patients with renal stones in lower pole of the kidney. Methods. We retrospectively analyzed the results of the retrograde intrarenal surgery in 24 patients with renal stones in lower pole, between April 2012 and April 2016. Flexible ureterorenoscopy in combination with holmium laser lithotripsy were performed. We considered stone fragment size 3 mm or less as a measure of sufficient fragmentation of the stone. Results. Mean duration of general anesthesia was 68 (range, 40?90) minutes. Duration of hospitalization was 1?3 (mean, 1.6) days. Complications were found after two (8.4%) surgical procedures: perirenal haematoma in one (4.2%) and urinoma in one (4.2%) patient. The stone was completely fragmented in 18 (75%) patients. In 3 (12.5%) patients the stone was incompletely fragmented and in 3 (12.5%) patients the stone was not fragmented. Double J stent was placed in 5 (21%) patients. Mean follow-up was 9 (range, 6?18) months. Conclusion. Retrograde intrarenal surgery in children is the least invasive, effective and safe surgical procedure for stones in lower pole of the kidney, with minimal complication rate. Unsuccessful treatment in some patients was due to loss of ureterorenoscope deflection with laser probe in working channel.


BMC Urology ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Yue He ◽  
You-Gang Feng ◽  
Jun He ◽  
Bo Liang ◽  
Ming-Dong Jiang ◽  
...  

Abstract Background Flexible ureteroscopic holmium laser lithotripsy is used to treat urinary tract calculi, but postoperative complications include shivering, fever and infection. To investigate the effects of irrigation fluid temperature on postoperative complications. Methods This randomized controlled trial included 120 consecutive patients undergoing flexible ureteroscopic holmium laser lithotripsy at the Urology Department, Suining Central Hospital, Sichuan, China between January 2017 and July 2019. Patients were randomized 1:1:1 into three groups (17 °C, 27 °C or 37 °C). Primary outcome was fever incidence (body temperature > 37.5 °C) within 48 h after surgery. Secondary outcomes included shivering incidence during recovery from anesthesia, white blood cell count (WBC), serum procalcitonin (PCT) and incidence of suspected infection (temperature > 38.5 °C and PCT > 0.5 µg/L). Results There were 108 patients, (17 °C group, n = 36; 27 °C group, n = 35; 37 °C group, n = 37), received flexible ureteroscopic holmium laser lithotripsy and analyzed. Age, gender distribution, body mass index, ASA grade, stone burden, preoperative creatinine, preoperative core temperature and irrigation fluid volume did not differ significantly between groups. 17 °C, 27 °C and 37 °C groups exhibited significant differences in the incidences of postoperative fever (38.9% vs. 17.1% vs. 13.5%) and shivering (22.2% vs. 5.7% vs. 2.7%) (p < 0.05 for all pairwise comparisons). There was no significant difference of WBC, PCT and incidence of suspected infection in 37 °C or 27 °C group compared with 17 °C group. One case each of flash pulmonary edema and bleeding occurred in 37 °C group. Conclusion Warming the irrigation fluid can reduce the incidence of postoperative fever and shivering, but further studies are needed to determine the optimal temperature. Trial registration The trial was registered at the Chinese Clinical Trials Registry and allocated as ChiCTR2000031683. The trial was registered on 07/04/2020 and this was a retrospective registration.


Sign in / Sign up

Export Citation Format

Share Document